Risk Evaluation and Mitigation Strategy assessments may be subject to performance goals under the next prescription drug user fee program.
Food and Drug Administration officials also have indicated they want funding to speed up the REMS assessment process. As part...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?